Thermo Fisher Scientific announced its acquisition of Mesa Biotech, a developer of point-of-care molecular diagnostic tests for infectious diseases, including COVID-19.
Merck KGaA announced a strategic collaboration with Artios Pharma, a company focused on DNA damage response therapies, to develop precision oncology treatment
s.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?